NMRA-861 has potential best-in-class pharmacology, which may enable a more favorable therapeutic profile No convulsions observed in...

Groundbreaking First-in-Human Study Establishes Potential to Treat Type 1 Diabetes by Transplanting Insulin-Secreting Cells Without...

Approval follows Priority Review and is supported by the robust TRUST clinical program, in which IBTROZI treatment demonstrated high,...

Boston, MA – May 27, 2025 – Indigo today announced that Microsoft has committed to purchase 60,000 soil carbon credits from the company’s...

Collaboration leverages City Therapeutics’ next-generation RNAi engineering technologies and Biogen’s extensive drug development...

• Presentation will highlight the comparable efficacy and safety of taletrectinib across pivotal studies and different ethnicities and...

EBR Systems, Inc. announced the US Food and Drug Administration (FDA) approval of EBR's WiSE cardiac resynchronisation therapy ("CRT")...

RMAT designation was granted based on promising clinical data from the ongoing Phase 1/2 trial of LYL314 in patients with relapsed and/or...

AI platform combined with autonomous labs will accelerate discovery across every domain of science Company has raised $200M in seed...